🇺🇸 FDA
Pipeline program

Vitamin A (retinyl palmitate)

(CIDA) (R/C Project 690/M3688)

Phase 2 small_molecule completed

Quick answer

Vitamin A (retinyl palmitate) for Vitamin A Deficiency is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Vitamin A Deficiency
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials